Lactobacillus johnsonii LJSD001 and its application in delaying aging

By independently isolating and identifying L.J.SD001 strain of L.J., a bacteria agent for delaying aging was developed, which solved the gap in the research related to L.J.J. in the prior art, and achieved the prolongation of lifespan and improvement of aging in female premature aging mice. The effect of relevant indicators provides new methods for treating aging.

CN117821282BActive Publication Date: 2024-12-03ZHEJIANG UNIV
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202310866388.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-07-14
Publication Date
2024-12-03
Estimated Expiration
2043-07-14

AI Technical Summary

Technical Problem

The biological phenotypes related to lifespan or aging in the prior art have not been studied, and there is a lack of effective probiotic treatment methods related to delaying aging.

Method used

The L.J. 001 strain of L. johnsonis was independently isolated and identified, and the effect of extending the lifespan of female premature aging mice was initially demonstrated through animal experiments. The bacterial agent containing this strain was developed to prepare preparations that delay aging, which were used to reduce natural aging female animals. , weak index, reduce liver lipid deposition, improve intestinal homeostasis, osteoporosis, muscle aging and neurological aging.

Benefits of technology

Effectively extend the lifespan of female premature aging mice, reduce the weakness index of naturally aged female animals, reduce liver lipid deposition, improve intestinal homeostasis, improve osteoporosis, improve muscle and neurological aging, and provide new ideas for the treatment of aging and plan.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117821282B_ABST
    Figure CN117821282B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of probiotics, and discloses a Lactobacillus johnsonii LJSD001 and its application in delaying aging. The LJSD001 bacteria are preserved in the General Microbiological Center CGMCC of the China Microbiological Culture Collection Administration Committee. The LJSD001 bacteria can delay the aging of female animals, especially prolong the life span of female premature aging animals, improve the cognitive level and spatial memory level of female naturally aging animals, and / or improve the neuroinflammation and synaptic plasticity of female naturally aging animals. It can be used as a beneficial supplement to the current limited probiotics for delaying aging, and can provide a new diagnosis and treatment direction for the treatment of related diseases such as cognitive impairment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of probiotics, specifically relates to Lactobacillus johnsonii LJSD001 and its application in delaying aging, especially in the preparation of products for delaying overall aging and multi-organ aging of female animals. Background Art

[0002] As the largest component of the host microbiome, the gastrointestinal microbiota contains at least 1000 different microbial species, with a total of 10 13 Up to 10 14 The total number of human cells (3-4×10 13 ) and is known as the second organ of the human body. The intestinal flora is not only closely related to the physiological functions of the gastrointestinal tract, but also participates in the occurrence and development of a variety of diseases, such as gastrointestinal diseases (inflammatory bowel disease, colorectal cancer), metabolic-related diseases (diabetes, obesity, non-alcoholic fatty liver disease), cardiovascular diseases and aging-related diseases.

[0003] Lactobacillus johnsonii is a Gram-positive facultative anaerobic bacterium of the Firmicutes phylum. It is the dominant species of Lactobacillus in the intestines of infants and is also commonly found in the intestines of adults. Previous studies have found that Lactobacillus johnsonii can maintain the homeostasis of the skin under ultraviolet irradiation by regulating the skin immune system. At the same time, Lactobacillus johnsonii can promote the secretion of anti-inflammatory cytokine IL-10 by activating natural macrophages, thereby alleviating acute and chronic colitis induced by dextran sulfate sodium (DSS). However, there is currently no research on the biological phenotypes of Lactobacillus johnsonii related to lifespan or aging. Summary of the invention

[0004] In a first aspect, the present invention provides a Lactobacillus johnsonii LJSD001. The Lactobacillus johnsonii (LJSD001) was independently isolated and collected.

[0005] The LJSD001 bacteria is isolated from feces, and the species level is confirmed by 16S rRNA gene sequencing, and is deposited in the China General Microbiological Culture Collection Center (CGMCC), with a deposit number of CGMCC NO.23929 and a strain name of Lactobacillus johnsonii-LJSD001 bacteria. The present invention uses it for the first time in related research on extending the lifespan of female progeria mice, and initial results are achieved. Animal experiments show that LJSD001 bacteria effectively extend the lifespan of female progeria mice. The strain has achieved unexpected results for previous Lactobacillus johnsonii strains, and is expected to be further developed into related drugs for delaying aging.

[0006] In a second aspect, the present invention also provides a bacterial agent containing Lactobacillus johnsonii LJSD001.

[0007] The bacterial agent can be a liquid bacterial agent or a solid bacterial agent, and can be a medicine, a health food or a food, and can contain a carrier and / or an excipient acceptable in the corresponding field; its dosage form can be a pill, a tablet, a powder, a capsule, a granule, a suspension, an injection, an oral liquid, an enema or a tube feeding preparation. When it is a liquid bacterial agent, the concentration of the LJSD001 bacteria is preferably 10 9 CFU / 200μL.

[0008] In a third aspect, the present invention also provides the use of the above-mentioned Lactobacillus johnsonii LJSD001 in the preparation of a preparation for delaying aging of female animals.

[0009] Provided is the use of the above-mentioned Lactobacillus johnsonii LJSD001 in preparing a preparation for any of the following uses:

[0010] Reduce the frailty index of naturally aged female animals;

[0011] Reduce liver lipid deposition in naturally aged female animals;

[0012] Improve intestinal homeostasis in naturally aged female animals;

[0013] Improve osteoporosis in naturally aged female animals;

[0014] Improve muscle aging in naturally aged female animals;

[0015] Improves neuroaging in naturally aging female animals.

[0016] The present invention has at least the following advantages and beneficial effects:

[0017] (1) LJSD001 bacteria can extend the lifespan of female premature aging animals. There are currently no relevant literature or patent reports. It can serve as a beneficial supplement to the limited probiotic treatment methods currently available.

[0018] (2) LJSD001 bacteria can reduce the frailty index of naturally aged female animals and has a certain application market in delaying aging.

[0019] (3) LJSD001 can reduce liver lipid deposition in naturally aged female animals and has certain application prospects in diseases related to liver lipid metabolism disorders;

[0020] (4) LJSD001 bacteria can maintain intestinal homeostasis in naturally aged female animals and has a certain application market in diseases related to intestinal homeostasis imbalance.

[0021] (5) LJSD001 bacteria can improve osteoporosis in naturally aged female animals, providing new clues and new ideas for the treatment of age-related osteoporosis.

[0022] (6) LJSD001 bacteria can improve muscle aging in naturally aged female animals and provide a new treatment option for age-related sarcopenia.

[0023] (7) LJSD001 bacteria can improve neuroaging in naturally aged female animals, providing new ideas for the treatment of age-related cognitive impairment. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1a , Figure 1b It is the whole genome sequencing diagram of LJSD001 bacteria in Example 1. In the figure, A is the Circos genome circle diagram analysis of LJSD001 bacteria; B is the comparative genome species evolution tree analysis of LJSD001 bacteria subspecies; C is the pan-genome Venn diagram analysis of LJSD001 bacteria subspecies.

[0025] Figure 2 The effect of LJSD001 bacteria in extending the life span of female progeria mice in Example 2. In the figure, A is the general view of male progeria mice intervened by PBS group and LJSD001 bacteria when the mortality rate of PBS group reached 50%; B is the general view of female progeria mice intervened by PBS group and LJSD001 bacteria when the mortality rate of PBS group reached 50%; C is the weight change of male and female progeria mice intervened by PBS and LJSD001 bacteria respectively; D is the survival curve of progeria mice intervened by PBS and LJSD001 bacteria respectively when gender is not distinguished; E is the survival curve of male progeria mice analyzed separately, after PBS and LJSD001 bacteria intervention; F is the difference in survival curve of female progeria mice analyzed separately, after PBS and LJSD001 bacteria intervention.

[0026] Figure 3 The effect of LJSD001 bacteria in improving the frailty index of naturally aged female mice in Example 3. In the figure, A is the general appearance of female naturally aged mice (Aged) and LJSD001 bacteria-intervention female naturally aged mice (Aged+Lj) at 19 months; B is the whole body aging index score of the two groups of naturally aged female mice after 10 months of intervention.

[0027] Figure 4The effect of LJSD001 bacteria in Example 4 on improving liver lipid deposition in naturally aged female mice. In the figure, A is the oil red staining showing the liver lipid deposition of naturally aged female mice (corresponding to Aged, Aged+Lj in the figure) treated with PBS and LJSD001 bacteria respectively, and young control female mice (corresponding to the Young group in the figure). B is the triglyceride content of naturally aged female mice and young control female mice treated with PBS and LJSD001 bacteria respectively detected by the triglyceride kit.

[0028] Figure 5 The effect of LJSD001 bacteria in improving the intestinal homeostasis of naturally aged female mice in Example 5. In the figure, A is the intestinal immunohistochemistry (HE) image, SA-β-gal staining and PAS staining of the three groups of mice in which PBS and LJSD001 bacteria were used to intervene in naturally aged female mice, and young female mice were used as controls; B is the protein image of P21 and P53, the intestinal aging indicators of the three groups of mice; C is the fluorescent labeled dextran (FITC-dextran) experiment representing the intestinal permeability of the three groups of mice; D is the intestinal mucus layer thickness image of the three groups of mice; E is the electron microscope image of the intestinal barrier protein of the three groups of mice; F is the change of the mRNA level of the intestinal barrier protein of the three groups of mice; G is the aging of the intestinal immune cell CD8T cells of the three groups of mice detected by flow cytometry; H is the aging of the intestinal immune cell CD4T cells of the three groups of mice detected by flow cytometry.

[0029] Figure 6 The effect of LJSD001 bacteria in improving osteoporosis in naturally aged female mice in Example 6. In the figure, A is a representative image of 3D reconstruction after micro-CT scanning of femoral samples of three groups of mice treated with PBS and LJSD001 bacteria (corresponding to Aged, Aged+Lj in the figure) and young control female mice (corresponding to the Young group in the figure); B is a comparison of bone volume fractions of the three groups of mice: bone volume / total volume (BV / TV); C is a comparison of trabecular bone number (Tb.N) of the three groups of mice.

[0030] Figure 7 The effect of LJSD001 bacteria in improving muscle aging in naturally aged female mice in Example 7. In the figure, A shows the muscle strength of three groups of mice treated with PBS and LJSD001 bacteria (corresponding to Aged, Aged+Lj in the figure, respectively) and young control female mice (corresponding to the Young group in the figure); B shows the protein level changes of muscle aging indicators in three groups of mice treated with PBS and LJSD001 bacteria (corresponding to Aged, Aged+Lj in the figure, respectively) and young control female mice (corresponding to the Young group in the figure).

[0031] Figure 8 The effect of LJSD001 bacteria in delaying cognitive decline in naturally aged female mice in Example 8. A is the novel object recognition index of the three groups of mice in the novel object recognition experiment of the naturally aged female mice (corresponding to Aged, Aged+Lj in the figure) and the young control female mice (corresponding to the Young group in the figure) treated with PBS and LJSD001 bacteria respectively; B is the accuracy rate of the three groups of mice in the Y maze experiment; C is the number of errors of the three groups of mice in the Y maze experiment; D is the average swimming speed of the three groups of mice in the Morris water maze experiment; E is the average latency time of the three groups of mice to find the platform during the training period in the Morris water maze experiment; F is the number of times the three groups of mice crossed the platform on the test day of the Morris water maze experiment; G is a representative figure of the swimming trajectory of the three groups of mice in the Morris water maze experiment; H is the latency time of the first crossing of the platform on the test day of the three groups of mice in the Morris water maze experiment.

[0032] Fig. 9 The LJSD001 bacteria in Example 9 can improve neuroinflammation and synaptic plasticity in naturally aged female mice. A is a representative transmission electron microscopy image of naturally aged female mice (corresponding to Aged, Aged+Lj in the figure) and young control female mice (corresponding to the Young group in the figure) treated with PBS and LJSD001 bacteria, respectively, comparing the ultrastructure of the blood-brain barrier of the three groups of mice, scale = 500nm; B is a representative image of Iba1 immunofluorescence staining in the CA1, CA3 and DG regions of the hippocampus of the three groups of mice, with a magnification of 400X; C is a representative image of Iba1 in each field of view in the CA1, CA3 and DG regions of the hippocampus of the three groups of mice. + Comparison of the number of microglia; D is a representative picture of Golgi staining of brain tissue of three groups of mice, magnification 400X. E is a statistical picture of Golgi staining of brain tissue of three groups of mice, comparing the number of dendritic spines per 50μm. DETAILED DESCRIPTION

[0033] The present invention is further described in detail below with reference to the accompanying drawings and specific embodiments.

[0034] Example 1: Isolation and Identification of Lactobacillus johnsonii (LJSD001)

[0035] The Lactobacillus johnsonii (LJSD001) described in this example was independently isolated by us, and the species level was confirmed by 16srRNA gene sequencing, and deposited in the China General Microbiological Culture Collection Center (CGMCC), with a preservation date of November 17, 2021; the preservation number is CGMCC NO.23929, and the strain name is Lactobacillus johnsonii-LJSD001.

[0036] 1. Strain isolation: Lactobacillus johnsonii is isolated from pig feces. Take 5g of feces, dilute it 10 times with sterile saline, take 0.1ml of the dilution with appropriate dilution and spread it evenly on MRS agar, culture it at 37℃ for 48h, and then inoculate the grown colonies into new MRS solid culture medium by streaking on the plate for purification and culture for 48h.

[0037] 2. Strain enrichment: Inoculate the purified strains one by one into sterile MRS broth medium using an inoculation loop on a sterile operating table, place them in a shaker, and culture them at 37°C for 48 hours before performing 16S rRNA gene identification.

[0038] 3.16S rRNA gene identification: The enriched bacterial liquid was amplified by colony PCR using bacterial universal primers and then sent to Shanghai Meiji Biological Company for 16S rRNA gene sequencing and identification. Sequence comparison was performed on NCBI, and it was found that the 16S rRNA gene sequence had the highest homology similarity with Lactobacillus johnsonii of the genus Lactobacillus johnsonii, confirming that the strain was Lactobacillus johnsonii.

[0039] 4. Whole genome identification: The above strains were further subjected to whole genome sequencing at Shanghai Meiji Biotechnology Co., Ltd., and Circos genome circle map analysis, comparative genome species evolutionary tree analysis and pan-genome Venn diagram analysis were performed.

[0040] The results are as follows Figure 1a As shown in A, the whole genome sequencing of the LJSD001 bacterial subspecies is completed and the Circos genome circle map analysis is performed. Figure 1b Figure B is the comparative genome species evolutionary tree analysis of the subspecies LJSD001. Figure 1C is the pan-genome Venn diagram analysis of the subspecies LJSD001. Based on the above results and literature research, this strain is different from the previously reported strains and is a newly discovered subspecies of Lactobacillus johnsonii.

[0041] Example 2: LJSD001 bacteria can extend the lifespan of female progeria mice

[0042] The LJSD001 bacterial strain stored at 1 mL-80°C was taken out and transferred to a small amount of sterilized MRS liquid culture medium for activation culture for 3 generations, wherein the small amount refers to the volume of the sterilized MRS liquid culture medium of 5-10 mL, in this embodiment, the sterilized MRS liquid culture medium is 10 mL, and the culture conditions are 37°C, 24 h; then the bacterial liquid was inoculated into a large amount of sterilized MRS liquid culture medium at a ratio of 2% and expanded and cultured at 37°C for 24 h, and then the viable bacteria were counted, in this embodiment, a large amount refers to the volume of the sterilized MRS liquid culture medium of 200 mL, and then the bacterial liquid was divided and centrifuged at 3000 r / min and 4°C for 15 min, and the supernatant was discarded to collect the bacteria; the bacterial suspension was resuspended with a PBS buffer solution of pH 7.0, and the concentration of the bacterial suspension was adjusted to 10 according to the viable bacteria count result. 9 CFU / 200 μL, stored at 4°C for future use, to obtain LJSD001 bacterial suspension, which was prepared again once a week.

[0043] Female Zmpste24- / - mice aged 6-8 weeks were randomly divided into 2 groups, 15 mice in each group. After one week of adaptation, the two groups were intragastrically administered with PBS and LJSD001 bacteria, respectively. The intragastrically administered volume of PBS was 200 μL, and the intragastrically administered dose of LJSD001 was 10 9 CFU / 200μL, once every other day. Record the survival curve of each mouse.

[0044] The results are as follows Figure 2 As shown, Figure 2 A and 2B show the overall appearance of progeria mice treated with LJSD001 bacteria and PBS, respectively. Figure 2 C shows the weight changes of progeria mice treated with LJSD001 bacteria and PBS. Figure 2 D shows the effect of LJSD001 bacterial intervention on the overall survival curve of progeria mice. Figure 2 E shows that LJSD001 bacterial intervention has no effect on the lifespan of male progeria mice. Figure 2 F shows that LJSD001 bacterial intervention can prolong the lifespan of female progeria mice.

[0045] Example 3: LJSD001 bacteria improves the frailty index of naturally aged mice

[0046] Female mice aged 10 months were randomly divided into 2 groups, 10 mice in each group. After one week of adaptation, the two groups were given PBS and LJSD001 bacteria by gavage, with PBS gavage volume of 200 μL and LJSD001 bacteria dose of 10 μL. 9 CFU / 200μL, once every other day. Frailty index scores were performed after 10 months of intervention.

[0047]

[0048]

[0049]

[0050]

[0051]

[0052] According to the indicators in the above table, the weakness index was calculated. The weakness index of each mouse was the sum of the scores of each item divided by the total number of items. Figure 3 Figure A shows the overall view of naturally aged female mice treated with LJSD001 bacteria and PBS; Figure B shows that the frailty index of naturally aged female mice treated with LJSD001 bacteria was lower than that of old mice treated with PBS. These data indicate that LJSD001 bacteria improves the frailty index of naturally aged female mice.

[0053] Example 4: LJSD001 bacteria improves lipid deposition in the liver

[0054] Female mice aged 10 months were randomly divided into two groups, 10 mice in each group. After one week of adaptation, the two groups were given PBS and LJSD001 bacteria by gavage, with PBS gavage volume of 200 μL and LJSD001 bacteria dose of 10 9 CFU / 200 μL per mouse, once every other day. After 10 months of intervention, 4-month-old female mice were taken as young controls, and the mice in the three groups were sacrificed for further studies.

[0055] The liver tissues of the three groups of mice were collected, fixed with 4% paraformaldehyde and then stained with oil red to evaluate the lipid deposition in the liver, and the triglyceride content in the liver was detected by a kit.

[0056] like Figure 4 A Oil red staining showed that naturally aged female mice treated with LJSD001 had less hepatic lipid deposition than those treated with PBS. Figure 4 B triglyceride kit detection, LJSD001 bacteria treated naturally aged female mice triglyceride content is lower.

[0057] Example 5: LJSD001 bacteria improves intestinal homeostasis

[0058] The above mice were sacrificed, and the colon tissues of the three groups of mice were collected: HE staining was performed after fixation with 4% paraformaldehyde to evaluate morphological changes, and PAS staining was performed to detect the carbohydrate content in the colon tissue; after fixation with aging-related β-galactosidase staining fixative, the staining solution was added and placed in a 37°C incubator for overnight incubation, and then observed and photographed under an optical microscope to evaluate the aging degree of colon tissue cells. The colon tissues of the three groups of mice were collected, and proteins were extracted for protein immunoblotting experiments to detect the expression of aging-related indicators such as p21 and p53. At the 20th month of old mice, the three groups of mice were gavaged with fluorescently labeled dextran (FITC-dextran) (the gavage volume was adjusted according to the weight of the mice, calculated as 0.6 mg / g). After 4 hours of gavage, peripheral blood was collected, and the FITC content in the serum was detected by a spectrophotometer (490nm) to evaluate intestinal permeability. Immunofluorescence technique was used to detect the thickness of the intestinal tissue mucus layer using Muc2 antibody: intestinal tissue containing a section of feces was retained, paraffin sectioned, and incubated with 1:500 concentration of Muc2 antibody to detect the intestinal tissue mucus layer of each group of mice, and the thickness was counted. Colon tissue was collected for scanning electron microscopy and transmission electron microscopy experiments to visually detect the colon epithelial mucus layer and barrier structure and evaluate the integrity of the intestinal mucosal barrier. Colon tissues of three groups of mice were collected, and mRNA was extracted and reverse transcribed into cDNA, and then fluorescence quantitative PCR experiments were performed to detect the expression of barrier-related indicators such as occludin, muc2, and zo-1. Immune cells in the intestinal lamina propria were collected, and T cell aging indicators were detected by flow cytometry.

[0059] The results are as follows Figure 5 As shown in A, SA-β-gal staining and PAS staining indicated that the degree of intestinal cell aging was significantly reduced in the LJSD001 bacteria intervention group. Figure 5 B shows that the protein expression levels of intestinal aging-related indicators p53 and p21 were significantly decreased in the LJSD001 bacteria intervention group. Figure 5 The fluorescence-labeled dextran (FITC-dextran) experiment in C showed that the intestinal permeability of elderly mice in the LJSD001 bacteria intervention group was significantly improved. Figure 5 D shows that Muc2 antibody immunofluorescence indicated that the mucus layer in the intestinal tissue of elderly mice in the LJSD001 bacteria intervention group was thicker. Figure 5 E shows that transmission electron microscopy of intestinal tissue more intuitively confirms that LJSD001 bacterial intervention can improve the tight junctions of the intestinal mucosa of elderly mice. Figure 5 Further fluorescence quantitative PCR experiments also showed that LJSD001 bacteria can increase the expression of tight junction proteins Occludin, Muc2 and Zo-1 in the intestinal cells of aged mice. Figure 5G and H detected the aging of intestinal immune cells by flow cytometry and found that LJSD001 bacteria can appropriately delay the aging of intestinal CD8T cells and CD4T cells. The above research results suggest that LJSD001 bacteria can improve the intestinal homeostasis of C57BL / 6 aged mice.

[0060] Example 6: LJSD001 bacteria can improve osteoporosis in naturally aged mice

[0061] After the three groups of mice were sacrificed, the femur samples of the three groups of mice were collected and fixed in 4% paraformaldehyde overnight, and then scanned by micro CT (InspeXio SMX-225CT FPD HR) at 225kV acceleration voltage and 4μm resolution. Then, under the same conditions, each sample was reconstructed using data analysis software VGStudio MAX (Volume Graphics, Heidelberg, Germany), and a cubic area of ​​the same volume was cut below the epiphyseal growth plate to analyze the bone volume fraction: bone volume / total volume BV / TV (bone volume / tissue volume), trabecular number Tb.N (trabecular number) reconstruction parameters, and evaluate the level of osteoporosis.

[0062] The results are as follows Figure 6 A shows representative 3D reconstruction images of femur samples from three groups of mice at 20 months of age after micro-CT scanning. Figure 6 B is a comparison of the bone volume fraction of the three groups of mice: bone volume / total volume (BV / TV). LJSD001 bacterial intervention can improve the bone volume fraction of naturally aged female mice. Figure 6 C is the comparison of the number of trabecular bones (Tb.N) in each group of mice. LJSD001 bacteria intervention can improve the number of trabecular bones in naturally aged female mice. LJSD001 bacteria can improve osteoporosis in naturally aged mice.

[0063] Example 7: LJSD001 bacteria can improve muscle aging in naturally aged mice

[0064] Before the mice were sacrificed, the three groups of mice were tested for grip strength. The grip strength tester was placed horizontally. After the instrument was turned on, the mice were placed on the grip board. The tail of the mice was grabbed and gently pulled back. After the mice grasped the grip board, they were pulled back evenly to loosen their claws. The instrument recorded the maximum grip strength of the mice. Each mouse was tested 3 times, and the average value was taken as the measurement result to evaluate the muscle strength of the mice.

[0065] The results are as follows Figure 7As shown in A, LJSD001 bacteria intervention has the ability to improve the muscle strength of aging mice. As further shown in 7B, LJSD001 bacteria intervention can reduce the expression of P53 aging protein in muscle tissue of aging mice. LJSD001 bacteria can improve muscle aging in naturally aging mice.

[0066] Example 8: LJSD001 bacteria can improve the cognitive ability of naturally aged mice

[0067] Before the mice were sacrificed, the three groups of mice underwent novel object recognition test, Y maze and Morris water maze test to evaluate the mice's cognitive level and spatial memory level.

[0068] A..New object recognition experiment: 24 hours before the test or training, place the mice in the test room to adapt to the test environment. At the beginning of the training, place two identical objects A and B on the left and right ends of one side wall, and place the mice in the field with their backs facing the two objects, and the distance between the tip of the mouse's nose and the two objects should be the same. The mice were put into the test for 10 minutes, and the video equipment was immediately turned on to record the number of times the mice contacted the two objects. After 10 minutes, the mice were immediately put back to the original cage and tested again 1 hour later. When testing again, the object B in the field was replaced with object C. Object C was different from object B. The mice were still placed with their backs facing the two objects, and the distance between the tip of the nose and the two objects was the same. The observation lasted for 5 minutes, and the video equipment was also used to record the number of times the mice explored object C and object A respectively. The recognition index (RI) calculation formula is: RI = the number of times the new object C was explored / (the number of times the new object C was explored + the number of times the old object A was explored) × 100%.

[0069] BY maze experiment: The Y maze consists of three identical arms, namely Area I, Area II, and Area III. The lower arm (Arm I) is usually set as the starting area, the left side (Arm II) is the safe area, the right side (Arm III) is the electric shock area, and the intersection of the three arms is the isolation area (Area 0). The mice were placed in the maze one day in advance and allowed to adapt for 5 minutes. The mice were given electric shocks in the starting area to cause them to escape to the safe area. The lights lasted for 15 seconds, then the lights were turned off and rested for 45 seconds before the next operation began. Each experiment was repeated 20 times on each mouse as one round. The experiment was carried out in a dark and quiet environment. Any reaction of the mouse escaping from the starting area to the safe area within 10 seconds after being shocked is called a "correct reaction", otherwise it is an "incorrect reaction". The learning standard is set as 9 or more correct reactions in 10 consecutive electric shocks. On the second day of the test day, each mouse was given 20 rounds of stimulation, and the number of "correct reactions" and "incorrect reactions" of each mouse was recorded.

[0070] C. Morris water maze test: The water maze has a diameter of 100 cm and a water depth of 21 cm. The inner wall of the pool has been sprayed with black plastic. The platform has a diameter of 9 cm and a height of 20 cm. The position of the platform cannot be seen from the water surface with the naked eye. The water temperature is 21-22°C. The test lasted for 8 days, with 6 days of training, 1 day of rest, and detection on the 8th day. Training period: The platform was placed in the northeast quadrant, and the mice were placed in the pool facing the pool wall from 3 different starting points. The free video recording system recorded the time (escape latency) and swimming path of the mice. After the mice found the platform or could not find the platform within 60 seconds (the latency was recorded as 60 seconds), the experimenter took them to the platform and rested on the platform for 10 seconds before the next test. The average of the latency of the mice in the three training sessions was used as the average latency of the mice on that day. Detection day: After the latency training was completed, the mice were tested for crossing the platform, that is, the underwater platform was removed, and the number of times the mice crossed the platform within 60 seconds and the latency of the first crossing of the platform were recorded. Image data analysis was performed using the SMART3.0 analysis system.

[0071] The results are as follows Figure 8 As shown in A, in the new object recognition experiment, the cognitive index of female aged mice was lower than that of young mice, but LJSD001 bacterial intervention could improve the cognitive index of female aged mice; Figure 8 As shown in Figures B and 8C, in the Y maze, female old mice showed lower accuracy and higher number of errors compared with female young mice. LJSD001 bacterial intervention can improve the accuracy and reduce the number of errors of female old mice. Further, the old mice after LJSD001 bacterial intervention were tested in the water maze. First, Figure 8 As shown in D, there was no difference in swimming speed between the two groups of aged mice; Figure 8 As shown in E, during the 6-day water maze training, the elderly mice treated with LJSD001 bacteria showed faster learning ability and gradually shortened the time to find the platform; Figure 8 As shown in FH, on the 8th day of the water maze test, the elderly mice treated with LJSD001 bacteria found the hidden platform location faster and crossed the platform location more frequently. In summary, supplementation with LJSD001 bacteria can significantly improve the cognitive level and spatial memory level of female elderly mice, suggesting that LJSD001 bacteria can delay cognitive decline in elderly female mice.

[0072] Example 9: LJSD001 bacteria can improve neuroinflammation and synaptic plasticity in female C57BL / 6 aged mice

[0073] After the three groups of mice were sacrificed, the ultrastructure of the blood-brain barrier was observed by transmission electron microscopy, the activation of microglia in the brain was detected by immunofluorescence, and the density of dendritic spines of mice was detected by Golgi staining.

[0074] Transmission electron microscopy: The cerebral cortical tissues on the left side of the three groups of mice were collected and quickly fixed in glutaraldehyde. After fixation for 24 hours, the cortical tissues were quickly dissected and divided into thin slices. The slices were fixed with 1% osmium tetroxide and then stained with a 2% aqueous solution of uranyl acetate. Then, they were dehydrated in a gradient with different concentrations of ethanol and acetone and then embedded in epoxy resin. Finally, the epoxy resin vessels were cut into ultrathin sections (70 nm) using an ultramicrotome and then stained on a copper grid with 4% uranyl acetate and lead citrate. TEM (Hitachi, HT7800, Japan) was used to observe the ultrastructure of the blood-brain barrier region of the three groups of mice.

[0075] Tissue immunofluorescence: Brain slices were dewaxed and hydrated for antigen retrieval, then blocked with 5% bovine serum albumin (BSA) for 30 min at room temperature, and then incubated with Iba1 (1:200) primary antibody overnight at 4°C. The cells were incubated with 488 secondary antibody (1:400) at 37°C for 1 hour. Finally, the cell nuclei of the sections were stained with DAPI (Cat. FD8396, Fude Biological technology, China). The images were taken using a Leica TCS SP8-DIVE two-photon microscope.

[0076] Golgi staining: The brain tissues of the three groups of mice were quickly washed with distilled water to remove the blood on the surface and then directly placed in a bottle of Golgi staining fixative, and sent to Sevier Biological Services Company for subsequent Golgi staining and scanning.

[0077] The results are as follows Fig. 9 As shown in A, transmission electron microscopy was used to detect the tight junctions of the cerebral cortex of female C57BL / 6 aged mice at 20 months of age, and it was found that exogenous supplementation of LJSD001 bacteria could enhance the tight junctions of the cerebral cortex of aged female C57BL / 6 mice; the activation of microglia is related to neuroinflammation and is considered to be crucial in the pathogenesis of neurodegenerative diseases. Its activation marker is Iba1. Fig. 9 Immunofluorescence staining (BC) showed that Iba1 was expressed in the CA3 and DG regions of the hippocampus of the aged mice. + The number of microglia was significantly higher than that of the young group, and exogenous supplementation of LJSD001 bacteria could significantly reduce the expression of Iba1 in the CA3 and DG regions of the hippocampus. + The number of microglia. Synaptic plasticity plays an important role in the signal transduction process of the nervous system. Golgi staining shows that, Fig. 9 As shown in DE, the density of dendritic spines in aged mice was significantly lower than that in the young group, while the density of dendritic spines after LJSD001 bacterial intervention was significantly higher than that in the aged group. The above research results suggest that LJSD001 bacteria can improve neuroinflammation and synaptic plasticity in aged female C57BL / 6 mice.

[0078] The above-mentioned specific implementation methods are used to explain the present invention and are only preferred embodiments of the present invention, rather than limiting the present invention. Any modifications, equivalent substitutions, improvements, etc. made to the present invention within the spirit of the present invention and the protection scope of the claims shall fall within the protection scope of the present invention.

Claims

1. Lactobacillus johnsonii ( Lactobacillus johnsonii ) LJSD001, It is characterized in that The Lactobacillus johnsonii ( Lactobacillus johnsonii ) LJSD001 is deposited in the General Microbiology Center of China Microorganism Culture Collection Administration with the deposit number: CGMCC NO.23929.

2. A method comprising the Lactobacillus johnsonii according to claim 1 ( Lactobacillus johnsonii ) LJSD001 bacterial agent.

3. The Lactobacillus johnsonii of claim 1 ( Lactobacillus johnsonii ) Use of LJSD001 in the preparation of a preparation for delaying the aging of female animals, wherein the delaying the aging of female animals is to extend the lifespan of female premature aging animals, improve the cognitive level and spatial memory level of female naturally aging animals, and / or improve neuroinflammation and synaptic plasticity of female naturally aging animals.

Citation Information

Patent Citations

  • Probiotic strain for ageing, muscle and bone, gut, hyperlipidemia, skin and brain

    CN112955539A